Group items tagged

Revitalize Respiratory Solutions is a pioneering company dedicated to providing cutting-edge respiratory services. Our expert team combines advanced technology with compassionate care to enhance the lives of individuals with respiratory challenges. From personalized treatment plans to state-of-the-art equipment, we strive to breathe new life into every breath.

British drug discovery company C4X Discovery said AstraZeneca had signed a licence worth up $402 million to develop an oral therapy for the treatment of inflammatory and respiratory diseases using its NRF2 Activator programme. The Manchester-based company said on Monday (November 28) it would receive pre-clinical milestone payments worth up to $16 million ahead of the first clinical trial, including $2 million upfront. In addition, C4XD said it would receive a further potential $385.8 million in clinical development and commercial milestones and tiered mid-single digit royalties upon commercialisation of any treatment.

It is common knowledge that human happiness and well-being are dependent on good health. According to The American Lung Association (ALA) though, lung cancer is the most common cause of cancer-related death in men and women as well. Unfortunately, it seems we often overlook the importance of our lungs. We tend to forget that they are nature's natural defensive system designed to keep dirt and germs out. However, there are several crucial things you can do to lower your lung disease risk. Here are some valuable guidelines for keeping your lungs in good shape. 1. AVOID EXPOSURE TO POLLUTION 2. NO SMOKING! 3. KEEP AWAY FROM INFECTIONS 4. TAKE DEEP BREATHS 5. EXERCISE REGULARLY These are the most essential and valuable guidelines that you should follow if you want your respiratory system to be healthy. Along with proper exercise, maintaining a balanced diet, and keeping your mind in a healthy vigorous state, they should form the foundation for long and prosperous life. Let's always keep in mind the teachings of ancient Greek philosophers, like Hippocrates, who maintained the axiom "a healthy mind in a healthy body", and we'll always be on the right track.

Genomic sequencing allowed the world to track new coronavirus variants throughout the pandemic. Now British researchers plan to use it to better understand a host of other respiratory pathogens, from influenza to respiratory syncytial virus (RSV). The work is aimed at shedding more light on known threats and, potentially, emerging ones, the team at the Wellcome Sanger Institute, working with the UK Health Security Agency, said. The world has never had access to the kind of real-time information for these viruses that scientists obtained on SARS-CoV-2 through sequencing millions of genomes, Ewan Harrison, head of the new Respiratory Virus and Microbiome Initiative, told reporters on Monday. That includes granular detail on how they transmit as well as how they evolve in the face of the human immune response. "We hope that by expanding our ability to sequence these viruses routinely, we can build upon the work that's going on COVID, and hopefully supercharge research efforts to understand the transmission of these viruses, but also to help develop new treatments and vaccines," Harrison said.

Pfizer on Thursday said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the illness through a second year of respiratory disease season. The company said in a press release that the vaccine's efficacy against RSV-associated lower respiratory tract disease with three or more symptoms was 77.8 per cent through season two, compared with efficacy of 88.9 per cent after the first RSV season, which led to the shot's US approval. The data is from a late-stage trial of more than 37,000 participants being conducted in both the Northern and Southern hemispheres. Cumulative efficacy over both seasons after around 16.4 months of disease surveillance was 81.5 per cent, Pfizer said. The data is similar to the efficacy of GSK's rival RSV shot Arexvy over two seasons, which was released in June.

As local GP services face increasing pressure, the role of pharmacists in managing minor ailments such as cold and cough has become more crucial than ever. Considering environmental and lifestyle factors, such as pollution levels, pollen counts, smoking, and diet, is essential for the effective management of respiratory conditions. In this article, experts explain how pharmacists can leverage these factors to provide more comprehensive advice to patients for managing cold and cough symptoms. Dr Roger Henderson, GP and spokesperson for Olbas, says: "Environmental factors play a critical role in the exacerbation and management of respiratory conditions. For example, high pollution levels can aggravate cold and cough symptoms, particularly in areas where air quality can drastically fluctuate. "By assessing real-time pollution data, pharmacists can advise patients to take precautions on days when pollution levels are high." Air pollution is well known to increase the risk of certain respiratory diseases.

Primary-care medicine is as much art as it is science, but clinicians sometimes rely too heavily on the former when it comes to prescribing antibiotics. Nowhere is this truer than in the treatment of respiratory tract infections (RTIs). Most cases of bronchitis are caused by viruses, but many clinicians prescribe antibiotics at their patients' insistence. Patients may explain that they are going on a long-planned vacation and just can't afford to be sick, or they are getting married that weekend and desperately need to get over an annoying cold.

Blue Customized Bracelets are the best way to raise awareness on Respiratory Care Week this October.

What Is Immunity? Immunity is the capability of an organism to sustain the "self" molecules that constitute its own body and to resist and destroy the "nonself" molecules which have their origin from toxins and infectious microorganisms. With increase in age, our immune response capability weakens and hence we become susceptible to respiratory infections like influenza, Covid-19, pneumonia and cancer. Nutrition and immunity are related to each other in the elderly people. Micronutrient malnutrition is a condition in which a person is deficient of some important essential vitamins and minerals as he or she eats less and often has less variety in the diet. They do not acquire the essential amounts of zinc, iron, folic acid, selenium, copper, vitamins A, B6, C, and E. If there is no time to prepare healthy daily diet, dietary supplements will surely help the older people to maintain a healthy immune system. Everyone Says Immunity! Really What Is Immunity Multimix from Indo French Lab is the best herbal tonic for all age groups, especially the elderly people. It maintains proper functioning of the lungs. It clears the respiratory system and gets rid of cough and cold. It increases the oxygen intake of your body and strengthens the lungs. There are many other healthcare products available at Indo French Labs.

The Pharmaceutical Services Negotiating Committee (PSNC) has reminded community pharmacy contractors to start working on the quality criteria if they intend to meet the Respiratory domain of the Pharmacy Quality Scheme (PQS) 2022/23. For respiratory domain, community pharmacy contractors  must start working towards inhaler waste management; use of a spacer in patients aged 5-15 years; and personalised asthma action plans, from today (10 October). Resources are also available to support contractors with meeting the above criteria on the PQS hub page. PSNC also informed that contractors are also now able to make a claim for an Aspiration payment for the PQS 2022/23 on the NHS Business Services Authority (NHSBSA)  Manage Your Service (MYS) portal. "The Aspiration payment is optional; if contractors do not want to claim it, it will not impact on the contractor's ability to claim a PQS payment during the declaration period. There is also no requirement to have claimed for a previous PQS to claim an Aspiration payment for PQS 2022/23.

Pharmaceutical giant GlaxoSmithKline aims to get its respiratory syncytial virus (RSV) vaccine to regulators for review later this year, after interim data showed the vaccine was effective in a keenly-watched late-stage study involving older adults. RSV is a leading cause of pneumonia in toddlers and the elderly, but the complex molecular structure of the virus and safety concerns have stymied efforts to develop a vaccine since the virus was first discovered in 1956. Companies including Pfizer, J&J, Sanofi, Moderna and AstraZeneca are also racing to get an RSV therapy or vaccine approved. The latest GSK trial is the first to show statistically significant efficacy for RSV in adults aged 60 years and older, the British drugmaker said of the ongoing study on Friday (June 10). If approved, the RSV vaccine is expected to generate billions for GSK, which is already the world's biggest vaccine maker by sales but has faced pressure from activist investors such as Elliott Management who have urged the London-based company to shore up its drug pipeline.

US biotech firm Moderna will build a new research and manufacturing centre in Britain to develop vaccines against new Covid-19 variants, other respiratory illnesses and help improve readiness for any future pandemics. The facility is expected to start producing shots in 2025 and Britain has made a commitment to buy Moderna's vaccines for the next decade under the agreement. Moderna's Covid-19 vaccines, which use messenger RNA (mRNA) technology, were among those deployed in Britain to tackle the crisis and enable prime minister Boris Johnson to reopen the economy from stringent lockdowns. Moderna chief executive Stephane Bancel said the priority was to develop a shot combining refreshed boosters against Covid, flu and Respiratory Syncytial Virus (RSV). "By building a plant in the UK, we are also providing the UK Government - which has a long term partnership with us, with this agreement - with the ability to be pandemic ready," Bancel said on Wednesday.

As Chair of the Council of Healthcare Professionals at Asthma + Lung UK, I'm deeply concerned about the invisible threat of air pollution on the health of our communities. It's a crisis that disproportionately affects the most disadvantaged, exacerbating health inequalities. Shockingly, for every 100 people who die from asthma in the UK, 31 are from the most deprived areas, compared to only 12 from the least. Studies have shown that the most economically disadvantaged are often those worst affected by air pollution, particularly because they often live near busy roads and yet are least likely to own a car. Wherever we live, the chance of breathing air that exceeds the World Health Organization's recommended pollution limits is alarmingly high. For the millions of Brits with lung conditions like asthma and COPD breathing in toxic air can harm their health and quality of life. Exposure to air pollution is directly linked to respiratory symptoms, hospitalisations, and the likelihood of developing respiratory diseases, even shortening life expectancy. Yet many people remain unaware of how much polluted air affects them. Often the first point of contact in healthcare, community pharmacists are well positioned to educate patients, especially those in polluted areas, about the impact of air pollution on their health.

Experts suggest that the new Respiratory Syncytial Virus (RSV) vaccination programme, being rolled out in hospitals and community pharmacies, will not only reduce the burden of RSV infections in England but also contribute to a reduction in antibiotic prescriptions. While antibiotics are ineffective against viruses, they are sometimes prescribed in primary care because it is difficult to distinguish between bacterial and viral infections. A study conducted by the UK Health Security Agency (UKHSA), Imperial College London, and Oxford Population Health revealed that RSV infections result in 640,000 antibiotic prescriptions a year. The study suggests that interventions to reduce RSV infections, including the new vaccine programme, could lower antibiotic use and, in turn, reduce antibiotic resistance. RSV typically causes mild respiratory symptoms in most individuals, but it can lead to serious illness and hospitalisation in vulnerable groups, such as infants and older adults.

In a collaborative effort, the National Health Services England (NHSE) is set to deliver the RSV(respiratory syncytial virus) vaccination programme where pharmacists alongside other healthcare professionals will play a crucial role in administering the vaccine. The UK Health Security Agency has announced the launch of the new vaccination programme targeting the respiratory syncytial virus (RSV), set to begin on 1 September 2024. Along with GPs, NHS England (NHSE) will "commission a number of community pharmacies to deliver the programme", ensuring broad accessibility and coverage to protect two high-risk groups: older adults and pregnant women. RSV is an RNA virus related to mumps, measles, and human parainfluenza viruses. It commonly causes coughs and colds in winter, transmitted through droplets and secretions from close contact with infected individuals. While most RSV infections are mild, infants under six months and the elderly are particularly susceptible to severe diseases like bronchiolitis and pneumonia, which can lead to hospitalisation.

Influenza, commonly shortened to "flu" is an extremely contagious respiratory illness caused by influenza A or B viruses. Flu appears most frequently in winter and early spring.

Black pepper is used in almost every recipe. It has long been known for the treatment of formation of intestinal gas. It also include respiratory disease, cough, common cold etc.

Black pepper is used in almost every recipe. It has long been known for the treatment of formation of intestinal gas. It also include respiratory disease, cough, common cold etc.

In this article we covered Flu Symptoms And Home Remedies. Influenza is a common respiratory illness that affects people from all age groups. Flu symptoms include a runny nose, sore throat, catarrh, and headache. Home remedies for flu are being used for centuries and have proven to be effective.

Influenza is a highly contagious, respiratory illness that affects people from all age groups and geographic backgrounds. In temperate regions, it occurs mostly in the winter months. There is no clear seasonal pattern in tropical climates. It varies in its severity from person to person. Sometimes, it presents as a mild, temporary infection. Other times, it can cause complications like red urine and ultimately lead to death. Influenza causes approximately 375,000 deaths worldwide each year.

The European Commission launched an initiative to deal with the ongoing supply crisis on Tuesday (24 October). The following announcement comes after the shortage of key antibiotics last winter identified by the European Health Emergency Preparedness and Response Authority (HERA) and the European Medicines Agency (EMA). The "European Voluntary Solidarity Mechanism" is a proposed short-term measure that involves a Member State's need for a given medicine to other Member States to redistribute medicines from their available stock. Additionally, the Commission intends to cooperate with member states to improve components of pharmaceutical reform with an aim to strengthen supply security. They are setting up a few actions apart from the launch, a list of critical medicines to analyse the supply chain by early 2024; regulatory flexibilities; strengthening security of supply; and availability of antibiotics and treatments for respiratory viruses by next winter.

The onset of ear infection symptoms is rapid. It is extremely important to detect ear infection symptoms at an early stage in order to determine accurate treatment and prevent further complications (such as ruptured eardrum and hearing loss). Usually, ear infection symptoms arise due to a bacterial or viral infection in the fluid that builds up inside the middle ear. In many cases, ear infection symptoms follow an upper respiratory related infection, such as a common cold, or a fever. Taking the pain away does not mean that the problem will be solved. It is much recommended to take a holistic comprehensive approach, taking care of the symptoms. Read more here on how to treat the ear infections without seeing a doctor.